Breast cancer is the leading cause of high mortality rates among women across the globe. Early diagnosis of breast cancer is the important step towards treatment, in order to avoid time delays, turning the cancers to malignant or metastatic. The market of breast imaging has witnessed dramatic technological evolutions since last few years. Every new technique came up with better solution to compensate the procedural gap of the last technique. At present, this market represents widely diverse technologies with newer and more comprehensive breast imaging devices.
Browse 10 tables and 38 figures spread through 130 slides combined with an in-depth TOC on “Breast Imaging Technologies Market (Digital Mammography, 3D Breast Tomosynthesis, Breast MRI, Breast Ultrasound, Molecular Breast Imaging, Optical Imaging, PET/CT/PEM Modalities) -Technology and Market Analysis & Global Forecasts to 2017”.
Early buyers will receive 10% customization on reports.
Currently, Mammography is the gold standard technology used for the detection and diagnosis of breast cancer. However, owing to its low sensitivity and risk of exposure to radiation, new alternative modalities are gaining importance for accurate detection of breast cancers. Nuclear and Magnetic Resonance imaging have been used to detect breast cancers in high risk patients. Recently, Full Field Digital Mammography, 3D breast Tomosynthesis, CT, PET, PEM, Optical imaging and Molecular Breast imaging techniques are also being used for breast cancer screening. Another upcoming modality is the Whole Breast Ultrasound (WBU) which is considered as much safer, user friendly for physicians and cost effective compared to other modalities.
With the growing R&D efforts in technology innovations and modality up-gradations, along with regulatory approvals, the market of breast imaging modalities for cancer diagnosis will witness a considerable growth from the year 2012 reaching approximately $5 billion by 2017.
North – Dominion Plaza,
17304 Preston Road,
Suite 800, Dallas, TX 75252